• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

NAFLD in lean individuals: not a benign disease.

作者信息

Francque Sven, Wong Vincent Wai-Sun

机构信息

Gastroenterology Hepatology, University Hospital Antwerp, Edegem, Antwerp, Belgium

Translational Research in Inflammation and Immunology (TW12N), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

出版信息

Gut. 2022 Feb;71(2):234-236. doi: 10.1136/gutjnl-2021-324162. Epub 2021 Mar 12.

DOI:10.1136/gutjnl-2021-324162
PMID:33712438
Abstract
摘要

相似文献

1
NAFLD in lean individuals: not a benign disease.瘦人非酒精性脂肪性肝病：并非良性疾病。
Gut. 2022 Feb;71(2):234-236. doi: 10.1136/gutjnl-2021-324162. Epub 2021 Mar 12.
2
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤，及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
3
Nonalcoholic fatty liver disease in lean individuals in the United States.美国瘦人群体中的非酒精性脂肪性肝病
Medicine (Baltimore). 2012 Nov;91(6):319-327. doi: 10.1097/MD.0b013e3182779d49.
4
Irisin in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的鸢尾素。
Metabolism. 2014 Feb;63(2):207-17. doi: 10.1016/j.metabol.2013.09.013. Epub 2013 Oct 18.
5
Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH).非酒精性脂肪性肝病（NAFLD）/非酒精性脂肪性肝炎（NASH）的分子机制。
Adv Exp Med Biol. 2021;1261:223-229. doi: 10.1007/978-981-15-7360-6_20.
6
Nonalcoholic fatty liver disease in Asia: emerging perspectives.亚洲的非酒精性脂肪性肝病：新视角。
J Gastroenterol. 2017 Feb;52(2):164-174. doi: 10.1007/s00535-016-1264-3. Epub 2016 Sep 16.
7
The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.美国生活方式引起的肥胖综合征饮食在雄性和雌性啮齿动物中再现了非酒精性脂肪性肝病和非酒精性脂肪性肝炎的临床和转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2020 Sep 1;319(3):G345-G360. doi: 10.1152/ajpgi.00055.2020. Epub 2020 Aug 5.
8
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model".儿童和青少年非酒精性脂肪性肝病的发病机制：从“双打击理论”到“多打击模型”。
World J Gastroenterol. 2018 Jul 21;24(27):2974-2983. doi: 10.3748/wjg.v24.i27.2974.
9
Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.非酒精性脂肪性肝病瘦患者的特征：高血红蛋白水平的潜在作用。
Scand J Gastroenterol. 2015 Mar;50(3):341-6. doi: 10.3109/00365521.2014.983160. Epub 2014 Dec 26.
10
Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.非酒精性脂肪性肝病在瘦人群体中的：预后、结局和管理。
World J Gastroenterol. 2020 Nov 14;26(42):6514-6528. doi: 10.3748/wjg.v26.i42.6514.

引用本文的文献

1
Predicting the risk of lean non-alcoholic fatty liver disease based on interpretable machine models in a Chinese T2DM population.基于可解释机器学习模型预测中国2型糖尿病患者发生瘦型非酒精性脂肪性肝病的风险
Front Endocrinol (Lausanne). 2025 Jul 11;16:1626203. doi: 10.3389/fendo.2025.1626203. eCollection 2025.
2
Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus.临床医护指导：糖尿病与代谢相关脂肪性肝病患者的处理——专家共识。
Hepatol Commun. 2024 Oct 30;8(11). doi: 10.1097/HC9.0000000000000571. eCollection 2024 Nov 1.
3
Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics.
代谢相关脂肪性肝病（MASLD）防治的健康功能性食品生物标志物：网络药理学、肠道微生物群和多组学的综合分析
Nutrients. 2024 Sep 11;16(18):3061. doi: 10.3390/nu16183061.
4
Metabolic dysfunction associated fatty liver disease in healthy weight individuals.代谢功能障碍相关的健康体重个体的脂肪肝疾病。
Hepatol Int. 2024 Oct;18(Suppl 2):884-896. doi: 10.1007/s12072-024-10662-w. Epub 2024 Jul 25.
5
What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside.瘦人代谢功能障碍相关脂肪性肝病的新进展：从 bench 到 bedside。 （注：“bench”和“bedside”在这里可能是比喻从基础研究到临床应用的过程，直译为“从实验台到病床边”，但这样表述稍显生硬，所以整体保留英文更符合语境。）
J Clin Med. 2024 Jan 3;13(1):278. doi: 10.3390/jcm13010278.
6
Genetic and Metabolic Characteristics of Lean Nonalcoholic Fatty Liver Disease in a Korean Health Examinee Cohort.韩国体检人群中瘦型非酒精性脂肪性肝病的遗传和代谢特征。
Gut Liver. 2024 Mar 15;18(2):316-327. doi: 10.5009/gnl230044. Epub 2023 Aug 10.
7
Insulin resistance in adipose tissue and metabolic diseases.脂肪组织中的胰岛素抵抗与代谢性疾病。
Diabetol Int. 2022 Dec 22;14(2):119-124. doi: 10.1007/s13340-022-00616-8. eCollection 2023 Apr.
8
Characteristics and long-term mortality of patients with non-MAFLD hepatic steatosis.非 MAFLD 性肝脂肪变性患者的特征和长期死亡率。
Hepatol Int. 2023 Jun;17(3):615-625. doi: 10.1007/s12072-023-10512-1. Epub 2023 Mar 31.
9
Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver disease.血清miR-4488作为瘦型非酒精性脂肪性肝病的潜在生物标志物。
Ann Transl Med. 2023 Feb 28;11(4):173. doi: 10.21037/atm-22-6620. Epub 2023 Feb 21.
10
NAFLD in type 1 diabetes: overrated or underappreciated?1型糖尿病中的非酒精性脂肪性肝病：被高估还是被低估？
Ther Adv Endocrinol Metab. 2021 Nov 23;12:20420188211055557. doi: 10.1177/20420188211055557. eCollection 2021.